Skip to main content
. 2016 Sep 7;18(1):200. doi: 10.1186/s13075-016-1097-8

Table 2.

Polymyalgia rheumatica (PMR)-related characteristics of responders

All Female Male P value
Median (IQR) pain score (NRS) 8 (7, 9) 8 (7, 10) 8 (7, 9) 0.0005
Median (IQR) stiffness score (NRS) 8 (7, 9) 8 (7, 9) 8 (6, 9) 0.0049
Times of day when stiffness present (n, %)a
 None 15 (2.3) 10 (2.5) 5 (2.0) 0.724
 Morning 619 (95.2) 387 (95.6) 232 (94.7) 0.617
 Lunchtime 368 (56.6) 227 (56.1) 141 (57.6) 0.708
 Afternoon 357 (54.9) 219 (54.1) 138 (56.3) 0.576
 Early evening 394 (60.6) 257 (63.5) 137 (55.9) 0.057
 Late evening 446 (68.6) 288 (71.1) 158 (64.5) 0.078
 During the night 467 (71.9) 302 (74.6) 165 (67.4) 0.047
Duration of morning stiffness (n, %) 0.491
 None 12 (1.9) 8 (2.0) 4 (1.7)
 1–15 minutes 31 (4.9) 16 (4.0) 15 (6.3)
 16–45 minutes 69 (10.8) 41 (10.3) 28 (11.7)
 46–60 minutes 72 (11.3) 50 (12.6) 22 (9.2)
  > 1 hour 454 (71.2) 283 (71.1) 171 (71.3)
Able to raise both arms above head when first saw GP (n, %) 0.101
 Yes 186 (28.8) 107 (26.6) 79 (32.5)
 No 413 (64.0) 261 (64.9) 152 (62.6)
 Don’t know 46 (7.1) 34 (8.5) 12 (4.9)
Use of prednisolone (n, %) 0.484
 Yes 626 (96.9) 390 (96.5) 236 (97.5)
 No 20 (3.1) 14 (3.5) 6 (2.5)
Other medications for PMR (n, %)a
 Paracetamol 248 (37.9) 176 (43.2) 72 (29.2) <0.0001
 Paracetamol and codeine 137 (21.0) 96 (23.6) 41 (16.6) 0.033
 Non-steroidal anti-inflammatories 69 (10.6) 44 (10.8) 25 (10.1) 0.781
 Strong prescription painkillers 86 (13.2) 62 (15.2) 24 (9.7) 0.043
 Gastro-protection 332 (50.8) 210 (51.6) 122 (49.4) 0.585
 Calcium and vitamin D 304 (46.5) 199 (48.9) 105 (42.5) 0.113
 Osteoporosis treatments 170 (26.0) 119 (29.2) 51 (20.7) 0.015
 Alternative therapies 26 (4.0) 20 (4.9) 6 (2.4) 0.115
 Anti-depressants 55 (8.4) 47 (11.6) 8 (3.2) <0.0001
 Other 100 (15.3) 55 (13.5) 45 (18.2) 0.105

aCan sum to >100 %, as respondents were able to choose more than one option. NRS numerical rating scales